SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

How Female Biology Could Solve the Mystery of Longevity

Why do women live longer than men? An evolutionary question sparks a new hypothesis that dovetails with a growing movement in longevity research.

Food Noise, Weight Stigma, and Managing Obesity

Why doesn’t food noise go quiet for everyone on GLP-1s? Why is the bias against them getting louder? And what does long-term obesity management actually look like?

Diabetes Technology Helps T1D but Also Adds Burdens

A qualitative survey finds both expected and less-appreciated hurdles with the use of insulin pumps, CGMs, and automated insulin delivery systems.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Latest News

Why do women live longer than men? An evolutionary question sparks a new hypothesis that dovetails with a growing movement in longevity research.

Why doesn’t food noise go quiet for everyone on GLP-1s? Why is the bias against them getting louder? And what does long-term obesity management actually look like?

A qualitative survey finds both expected and less-appreciated hurdles with the use of insulin pumps, CGMs, and automated insulin delivery systems.

A pediatric endocrinologist raises questions about use in youth without diabetes.

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

News All Time

Remote Program Aids Obesity Medication Access

Pharmacists and navigators can expand obesity drug access without doctor visits — but drug shortages, insurance hurdles, and paperwork, not patient willingness, are the real bottlenecks to scale.

India Wanted Red Flags on Chip Packets and Soda. Big Food Fought Back

A can of Fanta sold in London has 63 calories. Buy the same brand in India, and it contains three times as much sugar. It also includes artificial dye, whose presence in...

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Diabetes Prevention Starts Earlier Than Thought

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood, and adulthood.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

More US Employers to Drop Weight-loss Drugs in 2027, as Healthcare Costs Increase

About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see ⁠rising healthcare costs, according to a survey released on...

Trump's Weight; Fauci Gets a Legal Defense Fund; Eye Drops Recalled

— Health news and commentary gathered by MedPage Today staff

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

FDA Panel Endorses Lifting Restrictions on Peptides Backed by RFK Jr.

Votes go against agency scientists' recommendation to keep them off the compounding list

Judge Questions Hegseth's Testosterone Policy Amid Military's Transgender Care Ban

Parties ordered to address "similarities and differences in administering TRT" to both groups

1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid

Health news and commentary gathered by MedPage Today staff

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence

News and commentary from the endocrinology world

Recommended News For You

Are ultramarathon runners really at increased risk of bowel cancer?

Investigations may result in novel combination therapies for early-stage lung cancers.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

In inflammatory breast cancer, ER beta regulates estrogen signaling.

FDA Approves New Drug Combo for RR Multiple Myeloma

Recommended Articles For You

Clinical Pharmacology of Stromal-Targeted Anticancer Pharmacotherapy 

Financial Toxicity Reduction as a Population Cancer Care Priority 

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

2.

Childhood cancer survivors face new health problems later in life, study shows

3.

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

1.

Obesity is a major risk factor for cancer

2.

Prevention of Thrombotic Complications in High-Risk Patients

3.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

4.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

5.

The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder 

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Hands-on Workshop: Hematology

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

5.

Immunotherapy: A New Era in Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot